The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells
Open Access
- 1 January 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 99 (1) , 15-23
Abstract
The acute myelogenous leukemia–1 (AML1)–ETO fusion protein is generated by the t(8;21), which is found in 40% of AMLs of the French-American-British M2 subtype. AML1-ETO interferes with the function of the AML1 (RUNX1, CBFA2) transcription factor in a dominant-negative fashion and represses transcription by binding its consensus DNA–binding site and via protein-protein interactions with other transcription factors. AML1 activity is critical for the development of definitive hematopoiesis, and haploinsufficiency of AML1 has been linked to a propensity to develop AML. Murine experiments suggest that AML1-ETO expression may not be sufficient for leukemogenesis; however, like the BCR-ABL isoforms, the cellular background in which these fusion proteins are expressed may be critical to the phenotype observed. Retroviral gene transfer was used to examine the effect of AML1-ETO on the in vitro behavior of human hematopoietic stem and progenitor cells. Following transduction of CD34+ cells, stem and progenitor cells were quantified in clonogenic assays, cytokine-driven expansion cultures, and long-term stromal cocultures. Expression of AML1-ETO inhibited colony formation by committed progenitors, but enhanced the growth of stem cells (cobblestone area-forming cells), resulting in a profound survival advantage of transduced over nontransduced cells. AML1-ETO–expressing cells retained progenitor activity and continued to express CD34 throughout the 5-week long-term culture. Thus, AML1-ETO enhances the self-renewal of pluripotent stem cells, the physiological target of many acute myeloid leukemias.Keywords
This publication has 29 references indexed in Scilit:
- Alterations of the AML1 transcription factor in human leukemiaSeminars in Cell & Developmental Biology, 2000
- Exogenous cdk4 overcomes reducedcdk4 RNA and inhibition of G1 progression in hematopoietic cells expressing a dominant-negative CBF – a model for overcoming inhibition of proliferation by CBF oncoproteinsOncogene, 2000
- Fatal myeloproliferation, induced in mice by TEL/PDGFβR expression, depends on PDGFβR tyrosines 579/581Journal of Clinical Investigation, 2000
- Expression of the AML-1 Oncogene Shortens the G1Phase of the Cell CycleJournal of Biological Chemistry, 2000
- The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1Oncogene, 1999
- Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion geneNature Genetics, 1997
- The CBFβ Subunit Is Essential for CBFα2 (AML1) Function In VivoCell, 1996
- Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta.Proceedings of the National Academy of Sciences, 1996
- AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver HematopoiesisCell, 1996
- A cell initiating human acute myeloid leukaemia after transplantation into SCID miceNature, 1994